{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:05Z","timestamp":1786120325253,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1097\/aog.0b013e31822864af","type":"journal-article","created":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T08:34:51Z","timestamp":1327394091000},"page":"436-438","source":"Crossref","is-referenced-by-count":3,"title":["Antipsychotics Leading to Neuroleptic Malignant Syndrome in Pregnancy"],"prefix":"10.1097","volume":"119","author":[{"given":"Neda","family":"Ghaffari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Dossett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210126","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs.","volume":"65","author":"Ananth","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R3-8-20210126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes.","volume":"18","author":"Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"key":"R4-8-20210126","first-page":"906","article-title":"Neuroleptic malignant syndrome in pregnancy.","volume":"98","author":"Russell","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R5-8-20210126","first-page":"800","article-title":"Risk factors for neuroleptic malignant syndrome.","volume":"84","author":"Akpaffiong","year":"1992","journal-title":"J Natl Med Assoc"},{"key":"R6-8-20210126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0033-3182(88)72433-0","article-title":"Neuroleptic malignant syndrome in pregnancy.","volume":"29","author":"James","year":"1988","journal-title":"Psychosomatics"},{"key":"R7-8-20210126","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ncl.2003.12.006","article-title":"The evaluation and management of patients with neuroleptic malignant syndrome.","volume":"22","author":"Bhanushali","year":"2004","journal-title":"Neurol Clin"},{"key":"R8-8-20210126","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1176\/ajp.2006.163.12.2064","article-title":"Atypical antipsychotics in the treatment of schizophrenia during pregnancy and the postpartum.","volume":"163","author":"Yaeger","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R9-8-20210126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0920-9964(01)00370-X","article-title":"Women with schizophrenia: pregnancy outcome and infant death among their offspring.","volume":"58","author":"Nilsson","year":"2002","journal-title":"Schizophr Res"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201202001-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:31:04Z","timestamp":1786048264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201202001-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":8,"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e31822864af","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}